Viridian seeks Priority Review for veligrotug, aiming for a potential mid-2026 commercial launch if approved. Global phase 3 ...

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today reported financial results for ...

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated ...

(Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that the company will host a virtual ...

Fintel reports that on November 13, 2025, BTIG reiterated coverage of Sky Harbour Group (NYSE:SKYH) with a Buy recommendation ...

Crinetics Pharmaceuticals' stock has surged after FDA approval of Palsonify for acromegaly. Click here to read the latest analysis on CRNX stock now.

A once-daily oral quadruple receptor agonist induced up to 13.8% weight loss at 13 weeks among adults with overweight or ...

By Seade CAESAR  Ghana’s Metropolitan, Municipal, and District Assemblies (MMDAs) stand at a crossroads. Their permitting systems, essential for regulating land use and development, remain largely ...

Prediabetes burden is rising globally and in India. The latest IDF 2025 Atlas estimated that in 2024, 634.8 million adults (12%) worldwide had IGT, including 89.9 million in India, projected ...

Peptides have become an increasingly important area of research in numerous scientific fields, especially for their diverse functions.

The Government of Ghana has announced an ambitious total revenue and grants target of GH¢268.1 billion for the 2026 fiscal ...

The government has budgeted to spend GH¢302.5 billion for the 2026 fiscal year, representing 18.9 per cent of Gross Domestic Product (GDP).